Study of PF-07248144 in Advanced or Metastatic Solid Tumors

NCT04606446 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic ER+ HER2- Breast Cancer
Locally Advanced or Metastatic Castration-resistant Prostate Cancer
Locally Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: PF-07248144
DRUG: Fulvestrant
DRUG: Letrozole
DRUG: Palbociclib
DRUG: PF-07220060
DRUG: PF-07850327, ARV-471, vepdegestrant

Sponsor

Pfizer